481 related articles for article (PubMed ID: 19374532)
21. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
[TBL] [Abstract][Full Text] [Related]
22. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
23. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
24. Endocytic Transport of Polyplex and Lipoplex siRNA Vectors in HeLa Cells.
Lazebnik M; Keswani RK; Pack DW
Pharm Res; 2016 Dec; 33(12):2999-3011. PubMed ID: 27585903
[TBL] [Abstract][Full Text] [Related]
25. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
[TBL] [Abstract][Full Text] [Related]
26. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.
Even-Chen S; Barenholz Y
Biochim Biophys Acta; 2000 Dec; 1509(1-2):176-88. PubMed ID: 11118529
[TBL] [Abstract][Full Text] [Related]
27. Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.
Dakwar GR; Braeckmans K; Ceelen W; De Smedt SC; Remaut K
Drug Deliv Transl Res; 2017 Apr; 7(2):241-251. PubMed ID: 27631392
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
29. Transfection mechanisms of polyplexes, lipoplexes, and stealth liposomes in α₅β₁ integrin bearing DLD-1 colorectal cancer cells.
Adil MM; Erdman ZS; Kokkoli E
Langmuir; 2014 Apr; 30(13):3802-10. PubMed ID: 24635537
[TBL] [Abstract][Full Text] [Related]
30. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
[TBL] [Abstract][Full Text] [Related]
31. Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.
Kwon OJ; Kang E; Kim S; Yun CO
J Control Release; 2011 Oct; 155(2):317-25. PubMed ID: 21699929
[TBL] [Abstract][Full Text] [Related]
32. Biophysical and lipofection studies of DOTAP analogs.
Regelin AE; Fankhaenel S; Gürtesch L; Prinz C; von Kiedrowski G; Massing U
Biochim Biophys Acta; 2000 Mar; 1464(1):151-64. PubMed ID: 10704929
[TBL] [Abstract][Full Text] [Related]
33. In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids.
Gaucheron J; Boulanger C; Santaella C; Sbirrazzuoli N; Boussif O; Vierling P
Bioconjug Chem; 2001; 12(6):949-63. PubMed ID: 11716686
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
35. Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.
Gu L; Nusblat LM; Tishbi N; Noble SC; Pinson CM; Mintzer E; Roth CM; Uhrich KE
J Control Release; 2014 Jun; 184():28-35. PubMed ID: 24727076
[TBL] [Abstract][Full Text] [Related]
36. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.
Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J
Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418
[TBL] [Abstract][Full Text] [Related]
37. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models.
Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J
Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid-modified cationic niosomes for ocular gene delivery: improving transfection efficiency in retinal pigment epithelium.
Qin Y; Tian Y; Liu Y; Li D; Zhang H; Yang Y; Qi J; Wang H; Gan L
J Pharm Pharmacol; 2018 Sep; 70(9):1139-1151. PubMed ID: 29931682
[TBL] [Abstract][Full Text] [Related]
39. Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba.
Zorzi GK; Schuh RS; Maschio VJ; Brazil NT; Rott MB; Teixeira HF
Colloids Surf B Biointerfaces; 2019 Jan; 173():725-732. PubMed ID: 30384269
[TBL] [Abstract][Full Text] [Related]
40. Effect of the preparation procedure on the structural properties of oligonucleotide/cationic liposome complexes (lipoplexes) studied by electron spin resonance and Zeta potential.
Ciani L; Ristori S; Bonechi C; Rossi C; Martini G
Biophys Chem; 2007 Dec; 131(1-3):80-7. PubMed ID: 17950520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
